Beckman Coulter Board Member Retires After 14 Years of Service.Business Editors FULLERTON, Calif.--(BUSINESS WIRE)--Nov. 4, 2002 Beckman Coulter This article needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article. , Inc. (NYSE NYSE See: New York Stock Exchange :BEC) today announced Gavin Herbert, chairman emeritus and current director of Allergan, Inc., has retired from Beckman Coulter's board of directors effective October 31, 2002. Herbert was a charter member of Beckman Coulter's board of directors (post SmithKline era) since 1988. Over the years he participated on the audit and finance, organization and compensation, and nominating and corporate governance Corporate Governance The relationship between all the stakeholders in a company. This includes the shareholders, directors, and management of a company, as defined by the corporate charter, bylaws, formal policy, and rule of law. committees. Following Herbert's resignation, the size of the board will officially be reduced from 12 members to 11. "Gavin has been an integral part of our board, sharing his leadership abilities and his integrity for many years," said John P. Wareham, chairman of the board, president and chief executive officer for Beckman Coulter. "He has provided invaluable advice and counsel that have contributed significantly to the strength and enhancement of our company." Beckman Coulter, Inc. is a global biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. company, headquartered in Fullerton, California Fullerton is a city located in northern Orange County, California, United States. As of the 2000 census, the city had a total population of 126,003. It was founded in 1887 by George and Edward Amerige and named for George H. . The company develops and markets instruments, chemistries, software and supplies that simplify and automate laboratory processes throughout the biomedical testing biomedical test A test intended to evaluate qualitative or quantitative derangements in physiology and predict impaired health due to exposure to hazardous materials continuum. Through pioneering medical research and drug discovery, specialty testing, and patient care diagnostics, Beckman Coulter supports all phases of the battle against disease. Annual sales for the company totaled $2 billion in 2001, with 62% of this amount generated by recurring revenue from supplies, test kits and services. For more information, visit www.beckmancoulter.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion